Soares, Bernardo
Kanevsky, Gabriela
Teng, Chei Tung
Pérez-Esparza, Rodrigo
Bonetto, Gerardo Garcia
Lacerda, Acioly L. T.
Uribe, Erasmo Saucedo
Cordoba, Rodrigo
Lupo, Christian
Samora, Aline Medeiros
Cabrera, Patricia http://orcid.org/0000-0002-8696-4278
Funding for this research was provided by:
Janssen Pharmaceutical Companies of Johnson & Johnson
Article History
Accepted: 30 May 2021
First Online: 31 August 2021
Declarations
:
: This study was conducted in accordance with local institutional ethics committees or institutional review boards (see Online Resource InternalRef removed for a listing), the values of the Declaration of Helsinki, the current guidelines of the International Conference of Harmonization and Good Clinical Practice, applicable regulatory requirements, and the sponsor’s policy.
: All participants provided informed consent via a form approved by local institutional ethics committees or institutional review boards (see Online Resource InternalRef removed for a listing).
: Bernardo Soares and Patricia Cabrera were employees of Janssen-Cilag at the time of their work on this study; Bernardo Soares is currently affiliated with Sanofi – Brazil, and Patricia Cabrera is currently affiliated with Janssen Global Services, Inc. Gabriela Kanevsky and Aline Medeiros Samora are employees of Janssen-Cilag. Chei Tung Teng has consulted or served on an advisory board for Janssen Cilag Farmaceutica, Lundbeck do Brasil, Servier do Brasil, Abbott Laboratórios do Brasil, Medley Farmaceutica, Takeda Distribuidora, SEM, and Torrent do Brasil, and has received grant or research support from Abbott Laboratórios do Brasil, Libbs Farmaceutica, Lundbeck do Brasil, Medley Farmaceutica, Ache Laboratorios Farmaceuticos, Torrent do Brasil, Biolab Sanus Farmaceutica, Laboratorios Pfizer, Servier do Brasil, and Apsen Farmaceutica, and EMS. Rodrigo Pérez-Esparza and Rodrigo Cordoba report no conflicts of interest. Gerardo Garcia Bonetto has performed clinical research for Roche, Janssen, Eisay, Otsuka, Lumbek, and Pfizer. Acioly L.T. Lacerda has received consulting fees from Hoffmann-La Roche, Genentech, Janssen Pharmaceutical, Daiichi Sankyo, Cristalia Produtos Químicos e Farmacêuticos, Pfizer, Mantecorp Indústria Química e Farmacêutica, Libbs Farmacêutica, FQM Farma, and Sanofi-Aventis over the last 24 months and has received research fees from Janssen Pharmaceutical, Eli Lilly, Novartis, Biophytis, Celltrion, Azidus, H. Lundbeck A/S, Servier Laboratories, Hoffman-La Roche, FQM Farma, and Forum Pharmaceuticals. Erasmo Saucedo Uribe has served as a consultant for Janssen-Cilag. Christian Lupo has performed clinical research for Janssen Pharmaceuticals, Novartis, Eli Lilly, Lundbeck, Servier, AstraZeneca, Bago, Wyeth, Pfizer, Otsuka, Takeda, and Sunovion, and has served as a speaker for Eli Lilly, Servier, Lundbeck, Chobet, and Janssen Pharmaceuticals.